Detalhe da pesquisa
1.
Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma.
Blood
; 135(26): 2375-2387, 2020 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32299093
2.
Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under LenDex: a longitudinal analysis.
Blood
; 127(9): 1151-62, 2016 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26668134
3.
Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients.
Blood
; 127(25): 3165-74, 2016 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-27118453
4.
Sequential vs alternating administration of VMP and Rd in elderly patients with newly diagnosed MM.
Blood
; 127(4): 420-5, 2016 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26500339
5.
Critical analysis of the stringent complete response in multiple myeloma: contribution of sFLC and bone marrow clonality.
Blood
; 126(7): 858-62, 2015 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-26089396
6.
GEM2005 trial update comparing VMP/VTP as induction in elderly multiple myeloma patients: do we still need alkylators?
Blood
; 124(12): 1887-93, 2014 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25102853
7.
Outcomes with two different schedules of bortezomib, melphalan, and prednisone (VMP) for previously untreated multiple myeloma: matched pair analysis using long-term follow-up data from the phase 3 VISTA and PETHEMA/GEM05 trials.
Ann Hematol
; 95(12): 2033-2041, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27738789
8.
Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study.
Blood
; 120(8): 1589-96, 2012 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-22791289
9.
Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial.
Blood
; 120(13): 2581-8, 2012 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22889759
10.
Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies.
Haematologica
; 99(8): 1365-72, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24816239
11.
Outcome according to cytogenetic abnormalities and DNA ploidy in myeloma patients receiving short induction with weekly bortezomib followed by maintenance.
Blood
; 118(17): 4547-53, 2011 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-21900193
12.
Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials.
Haematologica
; 98(6): 980-7, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23445873
13.
Accuracy and prognostic impact of FDG PET/CT and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A Nation-Wide cohort study.
Cancer Med
; 12(6): 6536-6546, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36373169
14.
Unsupervised machine learning improves risk stratification in newly diagnosed multiple myeloma: an analysis of the Spanish Myeloma Group.
Blood Cancer J
; 12(4): 76, 2022 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35468898
15.
Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial.
Lancet Oncol
; 11(10): 934-41, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20739218
16.
CAR-T therapy in solid transplant recipients with post-transplant lymphoproliferative disease: case report and literature review.
Curr Res Transl Med
; 69(4): 103304, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34303899
17.
Predicting long-term disease control in transplant-ineligible patients with multiple myeloma: impact of an MGUS-like signature.
Blood Cancer J
; 9(4): 36, 2019 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30886139
18.
Correction: Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role.
Leukemia
; 33(4): 1056, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30846864
19.
Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials.
PLoS One
; 13(9): e0203392, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30192814
20.
Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role.
Leukemia
; 32(11): 2427-2434, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29515235